Patent details

EN | LT

LT - IN VITRO METHOD FOR PROGNOSIS OR PREDICTION OF RESPONSE BY PATIENTS WITH RHEUMATOID ARTHRITIS TO TREATMENT WITH TNF-alpha FACTOR BLOCKING AGENTS

EN - IN VITRO METHOD FOR PROGNOSIS OR PREDICTION OF RESPONSE BY PATIENTS WITH RHEUMATOID ARTHRITIS TO TREATMENT WITH TNF-alpha FACTOR BLOCKING AGENTS

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C12Q 1/68

European patent
(11)	Number of the document	2333110
(13)	Kind of document	T
(96)	European patent application number	09815707.6
	Date of filing the European patent application	2009-09-18
(97)	Date of publication of the European application	2011-06-15
(45)	Date of publication and mention of the grant of the patent	2014-11-19
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/ES2009/070388
	Date	2009-09-18

PCT application publication
(87)	Number	WO 2010/034864
	Date	2010-04-01

Priority applications
(30)	Number	Date	Country code
	200802713	2008-09-24	ES

Inventors
(72)	JULI CANO, Antonio, ES MARSAL BARRIL, Sara, ES

Grantee
(73)	Fundacio Institut de Recerca de l`Hospital Universitari Vall d`Hebron, Passeig Vall d`Hebron, 119-129, 08035 Barcelona, ES

Title
(54)	IN VITRO METHOD FOR PROGNOSIS OR PREDICTION OF RESPONSE BY PATIENTS WITH RHEUMATOID ARTHRITIS TO TREATMENT WITH TNF-alpha FACTOR BLOCKING AGENTS
	IN VITRO METHOD FOR PROGNOSIS OR PREDICTION OF RESPONSE BY PATIENTS WITH RHEUMATOID ARTHRITIS TO TREATMENT WITH TNF-alpha FACTOR BLOCKING AGENTS